Cite

HARVARD Citation

    Cao, L. et al. (2022). Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy. Biomaterials. p. . [Online]. 
  
Back to record